Technically another 3rd party could have forced Pfizer to increase their bid from the IER's low end valuation of 14.6c but I thought Pfizer always needed to increase this to at least the IER's prefer valuation of 20.8c for any chance of the YES vote.
Why you should vote YES - a professional investor's perspective, page-48
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #